Sign in
Taking people in United StatesNo phase

Colored light shone into the eyes for chronic pain and fibromyalgia

Tests different lights shown to the eyes in adults with chronic pain.

Key facts

Who runs it
University of North Carolina, Chapel Hill
Where
Chapel Hill, United StatesSee the site
Trial code
Registry title
Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity
Status
Recruiting
People taking part
20 people, planned
Started
25 Aug 2023
Expected to end
9 Oct 2027
Type of study
Interventional, 3 groups
Treatments tested
  • Green Light stimulation
  • Equal Energy White stimulation
  • S-cone modulating white light
Record updated
2 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with fibromyalgia or chronic low back pain. They will use a portable light device for 2 hours a day for 5 days.

Age
18 to 65 years
Sex
All
Disease stage
Fibromyalgia or chronic low back pain diagnosed by a doctor. Average pain greater than 4/10 at the start.

Main reasons for not taking part

  • Vision disorders causing severe vision loss or blindness
  • Color blindness (self-reported)
  • Pregnancy
  • History of seizure disorder
  • Being in prison

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adults greater than or equal to 18 and less than or equal to 65
  • Individuals who have been diagnosed with fibromyalgia or chronic low back pain by their physician
  • Individuals who experience an average pain severity greater than 4/10 in intensity at baseline
  • Willingness to wear a battery-operated portable ganzfeld light stimulator device for 2 hours per day at the same time each day (ideally complete the light therapy session between 5 am-10 am each morning) for 5 days
  • Alert and oriented, and able to provide informed consent
  • Ability to read and speak English to complete validated questionnaires

Who cannot take part

  • Vision disorders or conditions resulting in severe vision impairment or blindness
  • No other history or condition that would, in the investigator's judgment, indicate that the patient would very likely be non-compliant with the study or unsuitable for the study (e.g., might interfere with the study, confound interpretation, or endanger the patient)
  • History of seizure disorder
  • Individuals with self-report of color blindness
  • Prisoner Status
  • Pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of North CarolinaChapel Hill, United StatesContact: Matthew C Mauck, MD PhDTaking people

About the trial

What the trial wants to find out

Participants with chronic pain conditions including chronic low back pain and fibromyalgia may benefit from light stimuli presented to the retina to reduce chronic pain severity and pain sensitivity. Participants will be recruited into this study and will be presented with one of three uniform light stimuli via a wide-field ganzfeld in three conditions to determine the retinal mechanisms that reduce pain. This work will lead to a greater understanding of retinal mechanisms that contribute to pain and will assist the design of future studies to harness the potential of light based pain therapies.

The 3 groups in the trial

  • Equal energy white stimulusTreatment being tested

    Equal energy white light at 500 lux. The International Commission on Illumination (CIE) coordinates of this light are (x=y=0.33), indicating that the stimulus appears uniformly white which means that the activation of each of the three classes of photoreceptors are equivalent, thus silencing any chromatic opponency. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.

    Treatment: Equal Energy White stimulation

  • Green light stimulusTreatment being tested

    Green light at 500 lux. Participants will view 545 nm green light delivered via a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.

    Treatment: Green Light stimulation

  • S-cone modulating white lightTreatment being tested

    The S-cone modulating light stimulus will alternate between two light conditions at 500 lux that will activate the S-cones by about 100x differentially between the two conditions while maintaining the L- an M-cones at constant activation between the two alternating conditions using 427 nm versus 545 nm light. The stimulus will be delivered by a portable battery-operated ganzfeld light stimulation device for 2 hours per day for 5 consecutive days.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity
Plain-language title
Colored light shone into the eyes for chronic pain and fibromyalgiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05956067, who can take part
Record updated
2 November 2026